HOMA-IR

Clinical trials for HOMA-IR explained in plain language.

Never miss a new study

Get alerted when new HOMA-IR trials appear

Sign up with your email to follow new studies for HOMA-IR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New pill aims to boost power of popular weight loss drugs

Disease control Not yet recruiting

This study aims to see if adding a new oral medication called enobosarm to the injectable weight loss drug semaglutide helps people lose more weight than semaglutide alone. It will enroll 200 adults aged 65 and older with obesity. The main goal is to measure total body weight cha…

Matched conditions: HOMA-IR

Phase: PHASE2 • Sponsor: Veru Inc. • Aim: Disease control

Last updated Mar 20, 2026 14:48 UTC

HOMA-IR

Get alerted when new HOMA-IR trials appear

New pill aims to boost power of popular weight loss drugs